Barriers/Drivers | Current prevalence* | Proportional increase in IPTp (95% UI) |
---|---|---|
Removing user-fees for ANC medicines | 12.2% | 3.1% (1.4-6.5%) |
Providing IPTp guidelines to all facilities | 50.1% | 5.5% (1.9-15.1%) |
Integrating IPTp in routine ANC services | 96.0% | 3.2% (1.8-5.2%) |
Preventing stock-outs of SP | 10.7% | 6.8% (4.1-10.4%) |
Annual IPTp-training for providers | 30.2% | 13.9% (7.5-24.8%) |
Joint effect | 30.6% (20.7-44.2%) |